Insider · CIK 0001242066

JOYCE R TODD

Reports to the SEC for 2 companies · CORONA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001242066

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-07-01	Allergan plcPerformance-Based Restricted Stock UnitA Award	Chief Financial Officer	AAward	+18.7K sh	—	—	18,662
2014-07-01	Allergan plcStock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+17K sh	—	—	16,983
2013-12-06	Allergan plcS Sale	Chief Financial Officer	SSale	−7,500 sh	$165.51	−$1.24M	47,100
2013-12-06	Allergan plcS Sale	Chief Financial Officer	SSale	−7,100 sh	$166.16	−$1.18M	40,000
2013-11-06	Allergan plcS Sale	Chief Financial Officer	SSale	−7,500 sh	$158.42	−$1.19M	54,600
2013-11-05	Allergan plcS Sale	Chief Financial Officer	SSale	−15K sh	$157.01	−$2.36M	62,100
2013-10-08	Allergan plcG Gift	Chief Financial Officer	GGift	−19.4K sh	—	—	0
2013-10-08	Allergan plcG Gift	Chief Financial Officer	GGift	+19.4K sh	—	—	77,100
2013-10-07	Allergan plcG Gift	Chief Financial Officer	GGift	−54.4K sh	—	—	19,438
2013-10-07	Allergan plcG Gift	Chief Financial Officer	GGift	+54.4K sh	—	—	57,662
2013-10-01	Allergan Finance LLCD Disposition to Issuer	CFO-Global	DDisposition to Issuer	−73.8K sh	—	—	0
2013-10-01	Allergan Finance LLCD Disposition to Issuer	CFO-Global	DDisposition to Issuer	−3,283 sh	—	—	0
2013-10-01	Allergan plcA Award	Chief Financial Officer	AAward	+73.8K sh	—	—	73,812
2013-10-01	Allergan plcA Award	Chief Financial Officer	AAward	+3,283 sh	—	—	3,283
2013-09-30	Allergan Finance LLCA Award	CFO-Global	AAward	+38.4K sh	—	—	118,913
2013-09-30	Allergan Finance LLCF Tax Payment	CFO-Global	FTax Payment	−45.1K sh	$144.00	−$6.49M	73,812
2013-08-14	Allergan Finance LLCS Sale	CFO-Global	SSale	−11K sh	$137.85	−$1.52M	84,470
2013-08-14	Allergan Finance LLCS Sale	CFO-Global	SSale	−4,000 sh	$138.35	−$553K	80,470
2013-03-15	Allergan Finance LLCF Tax Payment	CFO-Global	FTax Payment	−931 sh	$91.59	−$85.3K	95,470
2013-03-06	Allergan Finance LLCA Award	CFO-Global	AAward	+7,960 sh	—	—	89,685
2013-03-06	Allergan Finance LLCA Award	CFO-Global	AAward	+6,716 sh	—	—	96,401
2013-03-05	Allergan Finance LLCF Tax Payment	CFO-Global	FTax Payment	−1,919 sh	$86.46	−$166K	81,725
2013-03-02	Allergan Finance LLCF Tax Payment	CFO-Global	FTax Payment	−3,834 sh	$85.54	−$328K	83,644
2012-10-31	Allergan Finance LLCA Award	CFO-Global	AAward	+5,817 sh	—	—	87,478
2012-08-01	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+2,612 sh	$38.92	+$102K	80,847
2012-08-01	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+4,388 sh	$38.92	+$171K	85,235
2012-08-01	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+2,250 sh	$35.11	+$79K	87,485
2012-08-01	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+574 sh	$25.64	+$14.7K	88,059
2012-08-01	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+3,426 sh	$25.64	+$87.8K	91,485
2012-08-01	Allergan Finance LLCS Sale	CFO-Global	SSale	−2,612 sh	$78.60	−$205K	88,873
2012-08-01	Allergan Finance LLCS Sale	CFO-Global	SSale	−4,388 sh	$78.60	−$345K	84,485
2012-08-01	Allergan Finance LLCS Sale	CFO-Global	SSale	−2,250 sh	$78.60	−$177K	82,235
2012-08-01	Allergan Finance LLCS Sale	CFO-Global	SSale	−574 sh	$78.60	−$45.1K	81,661
2012-08-01	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	CFO-Global	MExercise/Conversion	−2,612 sh	—	—	0
2012-08-01	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	CFO-Global	MExercise/Conversion	−4,388 sh	—	—	0
2012-08-01	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	CFO-Global	MExercise/Conversion	−2,250 sh	—	—	0
2012-08-01	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	CFO-Global	MExercise/Conversion	−574 sh	—	—	0
2012-08-01	Allergan Finance LLCIncentive Stock Options to Purchase Common StockM Exercise/Conversion	CFO-Global	MExercise/Conversion	−3,426 sh	—	—	0
2012-05-25	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+5 sh	$26.40	+$132	78,235
2012-05-25	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	CFO-Global	MExercise/Conversion	−5 sh	—	—	0
2012-03-14	Allergan Finance LLCF Tax Payment	CFO-Global	FTax Payment	−1,067 sh	$59.21	−$63.2K	78,230
2012-03-08	Allergan Finance LLCA Award	CFO-Global	AAward	+8,356 sh	—	—	71,599
2012-03-08	Allergan Finance LLCA Award	CFO-Global	AAward	+7,698 sh	—	—	79,297
2012-02-24	Allergan Finance LLCF Tax Payment	CFO-Global	FTax Payment	−1,625 sh	$58.17	−$94.5K	63,243
2011-10-30	Allergan Finance LLCF Tax Payment	CFO-Global	FTax Payment	−1,175 sh	$69.35	−$81.5K	64,868
2011-08-24	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+3 sh	$27.88	+$83.64	54,914
2011-08-24	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+2,141 sh	$26.40	+$56.5K	57,055
2011-08-24	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+2,854 sh	$26.40	+$75.3K	59,909
2011-08-24	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+4,142 sh	$26.14	+$108K	64,051
2011-08-24	Allergan Finance LLCM Exercise/Conversion	CFO-Global	MExercise/Conversion	+7,858 sh	$26.14	+$205K	71,909

Recent filings

Accepted (ET)
Jul 34
Actavis plc0001179110-14-011534
SEC(opens sec.gov)
Dec 64
Actavis plc0001179110-13-017556
SEC(opens sec.gov)
Nov 74
Actavis plc0001179110-13-016285
SEC(opens sec.gov)
Oct 104
Actavis plc0001179110-13-015450
SEC(opens sec.gov)
Oct 34
Actavis plc0001179110-13-015199
SEC(opens sec.gov)
Oct 24
Actavis, Inc.0001179110-13-015054
SEC(opens sec.gov)
Aug 154
Actavis, Inc.0001179110-13-013190
SEC(opens sec.gov)
Mar 184
JOYCE R TODD0001179110-13-005307
SEC(opens sec.gov)
Mar 84
JOYCE R TODD0001179110-13-004744
SEC(opens sec.gov)

Companies

Address

C/O WATSON PHARMACEUTICALS, INC. 311 BONNIE CIRCLE

CORONA, CA, 92880